Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
By Larry Alphs, MD, PhD, John Panagides, PhD, and Scott Lancaster, MS
Addressing Methodological Issues in Studying Antidepressant Onset Efficacy Using Prespecified Sensitivity Analyses
By Ilya Lipkovich, PhD, Craig H. Mallinckrodt, PhD, Apurva Prakash, BA, and Andrew A. Nierenberg, MD